Stabilize Business Operations by Systematically Eliminating Waste & Building a Culture of Continuous Improvement to Deliver Advanced Therapies Just-in-Time for All Patients

Boston Event Guide
Washington D.C. Event Guide

Welcome to the LEAN Cell & Gene Event Series!

Manufacturing Advanced Therapies Just-In-Time for All Patients

The cell and gene therapy field has seen real breakthroughs, life-changing treatments, growing clinical validation, and a number of approved products. Yet, challenges remain: capital is limited, resources are tight, and many organizations are facing pressure to do more with less.

That’s where the LEAN Cell & Gene Event Series comes in. Designed for those working across development and manufacturing, this series offers a fresh perspective on how LEAN thinking can support better decisions, stronger operations, and more resilient organizations.

These principles aren’t new, but in today’s climate, they matter more than ever. From reducing waste and improving consistency to building a culture of continuous improvement, LEAN approaches provide practical, low-cost ways to strengthen your programs now and, prepare for what’s next.

Whether you’re early in development or further along, this event series features a collection of case studies on tried and tested methods to optimize CGT manufacturing from the likes of Immatics, Stanford, the NIH, Charles River Labs and more.

Now comprising of two events, one in Boston the other in D.C National Harbor, we’re ensuring you can engage with leading experts and gain practical insights in the biggest cell therapy hubs in North America helping you stay at the forefront of innovation and operational excellence.

 

Boston

September 22, 2025 I Boston, MA

Event Guide
Register

Washington D.C.

November 6, 2025 I Washington D.C.

Event Guide
Register

Attend the LEAN Cell & Gene Summit Series to:

Hear from LEAN Cell & Gene Leaders

Learn how LEAN principles are being successfully applied in CGT to reduce manufacturing overhead, shorten development timelines, and improve cost-efficiency across the product lifecycle

Stabilize Operations

Hear from leading academic, clinical, and commercial CGT institutions on practical ways to stabilize operations and do more with less

Logarithmically Increase Throughput

Explore how a G-Rex production system enables higher throughput through parallel processing, shorter cycle times, and single-piece (continuous) flow

Structurally Reduce Cost

Review how operational excellency and continuous improvement can lead to structurally reduced cost through the systematic identification and elimination of waste

Achieve Total Patient Access

Connect with peers and industry leaders during sessions and networking opportunities to exchange ideas on how we can deliver quality drug product just-in-time to the total addressable patient population

“CGT companies are now faced with a mission critical challenge of preserving capital and establishing a truly scalable manufacturing platform.

Virtually every other industry has met that challenge by adopting LEAN manufacturing principles.

The time has arrived for the CGT field get on board.”

John Wilson, Co-Inventor of G-Rex & Chief Executive Officer, Wilson Wolf

ScaleReady provides the field of cell and gene-modified cell therapy (CGT) with a G-Rex centric manufacturing platform that enables the world's most practical, flexible, scalable, and affordable CGT drug product development and manufacturing.

The G-Rex manufacturing platform is currently used by a rapidly growing list of over 800 organizations and is producing drug products for approximately 50% of CGT clinical trials as well as 5 commercially approved CGT drugs.

CGT entities relying on the breadth and scope of ScaleReady's expertise can expect to save years of time and millions of dollars on the path to CGT commercialization.

Learn More